SCHEMBL28807501

SCHEMBL28807501

NOC(=O)C1CCN(C(=O)O)CC1

nearest known ligand 0.41

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 4/20 0.41
MAPT P10636 2/20 0.40
ALDH1A1 P00352 4/20 0.38
GAA P10253 2/20 0.38
POLB P06746 1/20 0.38
NPC1 O15118 1/20 0.36
RAB9A P51151 1/20 0.36
TP53 P04637 1/20 0.35
HRH3 Q9Y5N1 1/20 0.35
LMNA P02545 1/20 0.34
CYP2C19 P33261 2/20 0.34
CYP3A4 P08684 1/20 0.34
CYP2D6 P10635 1/20 0.34
CYP2C9 P11712 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL485162 0.79 SMN1; SMN2 (0.62) SMN1; SMN2MAPTALDH1A1GAAPOLB
SCHEMBL14344751 0.79 CPN1 (0.41) SMN1; SMN2MAPTALDH1A1GAAPOLB
SCHEMBL13270668 0.77 TP53 (0.40) SMN1; SMN2MAPTALDH1A1GAAPOLB
SCHEMBL24684871 0.77 KMT2A (0.36) SMN1; SMN2RAB9ATP53LMNA
SCHEMBL669086 0.77
SCHEMBL14448370 0.76 SMN1; SMN2 (0.39) SMN1; SMN2MAPTALDH1A1GAAPOLB
SCHEMBL2030080 0.76 GAA (0.55) SMN1; SMN2ALDH1A1GAARAB9ACYP2C19
SCHEMBL4272598 0.76 GAA (0.33) SMN1; SMN2GAACYP2C19
SCHEMBL587681 0.75 LMNA (0.53) SMN1; SMN2MAPTALDH1A1GAAPOLB
SCHEMBL310852 0.75 HRH3 (0.60) SMN1; SMN2MAPTALDH1A1HRH3LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-103534265-A Cyclic peptides with an anti-neoplasic and anti-angiogenic activity CT INGENIERIA GENETICA BIOTECH 2014-01-22 CN claimed
CN-103534265-A Cyclic peptides with an anti-neoplasic and anti-angiogenic activity CT INGENIERIA GENETICA BIOTECH 2014-01-22 CN disclosed